GlaxoSmithKline places its shingles vaccine Shingrix among its top prospects, with peak sales potential of almost $6 billion. Now, Pfizer and BioNTech are joining forces to try to grab a slice of ...

Patients with inflammatory arthritis would benefit from vaccination against herpes zoster, with the Shingrix vaccine showing a crude effectiveness of 50%.

16.10.2017: Perspectives - New knowledge regarding the infectiousness and less frequent clinical manifestations of the varicella zoster virus should have consequences for infection prevention and ...